Stockshots of Danish drugmaker Novo Nordisk's existing and new production facility in Hillerod, on the outskirts of Copenhagen, and headquarters in Bagsvaerd. Europe's most valuable company is booming, thanks in part to the success of Ozempic, an anti-diabetic drug that has been hailed on social networks for its weight-loss benefits. To keep up with demand, the company has begun building new production facilities, including in Hillerod, which will not be active before 2029. STOCKSHOTS